Menu
Recruiting NCT04581122

A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components

No phase Interventional Progression

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Lymphadenectomy.
Who it may be relevant to
Registry conditions: Progression. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Zhongshan Hospital

Overview

A multiple-center study on the effect of different ways of lymph node dissection on the prognosis of less than 3cm ground glass nodules with more than solid components

Interventions

  • Procedure Lymphadenectomy
    Patients with ground glass nodules smaller than 3cm and with more than 50%solid components would randomly assigned to selective lymphadenectomy group or systematic lymph node dissection group

Primary outcome measures

  • overall survival (OS) [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 75 years;
  • GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
  • The maximum diameter of the GGO is smaller than 3cm;
  • The maximum diameter of the solid component in the GGO is more than 50%;
  • The patient is able to undergo the lobectomy
  • The patient is able to understand and comply with the study and has provided written informed consent.

Exclusion criteria

\-

Patients meeting any of the following criteria are not eligible for this trial:

  • Patients with a history of using immunosuppressive or hormonal drugs;
  • Patients receiving radiotherapy or chemotherapy;
  • Patients who fail to comply with our follow-up strategy;
  • Other situations that are not in conformity with the standards and requirements of this trial.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

China · 1 center
  • Jiang Wei — Shanghai

Identifiers

NCT: NCT04581122 · B2020-164R

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗